Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Guanidinoacetic Acid is a metabolite of glycine in which the amino group has been converted into a guanidine. Guanidinoacetic Acid is a direct precursor of creatine and is used as a supplement. Taking guanidinoacetic acid can increase muscle strength and slow muscle fatigue, etc. And add guanidinoacetic acid into fodder can make lean pig's body improve significantly.
However the metabolism of creatine from Guanidinoacetic Acid in the liver causes a depletion of methyl groups. This causes homocysteine levels to rise, which has been shown to produce cardiovascular and skeletal problems. A series of studies showed that a combination of betaine and Guanidinoacetic Acid improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine can provide a methyl group to glycocyamine, via methionine, for the formation of creatine. In overall, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. The patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure had improved cardiac function. The patients gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido, and those people suffering from hypertension experienced transient reduced blood pressure. Also the studies shows the increase of glucose tolerance in both diabetic subjects and subjects without diabetes.
The main market players are Evonik, Tiancheng Chempharm, Jiangsu Yuanyang, Hubei Yuanhua, Hebei Daxiao and GENDONE, with about 50% market shares.
Market Analysis and Insights: Global Guanidinoacetic Acid Market
In 2020, the global Guanidinoacetic Acid market size was US$ 33 million and it is expected to reach US$ 45 million by the end of 2027, with a CAGR of 4.1% during 2021-2027.
Global Guanidinoacetic Acid Scope and Market Size
Guanidinoacetic Acid market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Guanidinoacetic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
Segment by Type, the Guanidinoacetic Acid market is segmented into
Feed Grade
Pharmaceutical Grade
Others
Segment by Application, the Guanidinoacetic Acid market is segmented into
Fodder
Medicine
Others
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Guanidinoacetic Acid market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Guanidinoacetic Acid product introduction, recent developments, Guanidinoacetic Acid sales by region, type, application and by sales channel.
The major companies include:
Evonik
Tiancheng Chempharm
Jiangsu Yuanyang
Hubei Yuanhua
Hebei Daxiao
GENDONE
Shijiazhuang Zexing Group
Lubon Industry
However the metabolism of creatine from Guanidinoacetic Acid in the liver causes a depletion of methyl groups. This causes homocysteine levels to rise, which has been shown to produce cardiovascular and skeletal problems. A series of studies showed that a combination of betaine and Guanidinoacetic Acid improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine can provide a methyl group to glycocyamine, via methionine, for the formation of creatine. In overall, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. The patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure had improved cardiac function. The patients gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido, and those people suffering from hypertension experienced transient reduced blood pressure. Also the studies shows the increase of glucose tolerance in both diabetic subjects and subjects without diabetes.
The main market players are Evonik, Tiancheng Chempharm, Jiangsu Yuanyang, Hubei Yuanhua, Hebei Daxiao and GENDONE, with about 50% market shares.
Market Analysis and Insights: Global Guanidinoacetic Acid Market
In 2020, the global Guanidinoacetic Acid market size was US$ 33 million and it is expected to reach US$ 45 million by the end of 2027, with a CAGR of 4.1% during 2021-2027.
Global Guanidinoacetic Acid Scope and Market Size
Guanidinoacetic Acid market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Guanidinoacetic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
Segment by Type, the Guanidinoacetic Acid market is segmented into
Feed Grade
Pharmaceutical Grade
Others
Segment by Application, the Guanidinoacetic Acid market is segmented into
Fodder
Medicine
Others
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
and Guanidinoacetic Acid Market Share AnalysisGuanidinoacetic Acid market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Guanidinoacetic Acid product introduction, recent developments, Guanidinoacetic Acid sales by region, type, application and by sales channel.
The major companies include:
Evonik
Tiancheng Chempharm
Jiangsu Yuanyang
Hubei Yuanhua
Hebei Daxiao
GENDONE
Shijiazhuang Zexing Group
Lubon Industry
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
